TickerFacts.

Axim Biotechnologies, Inc. (AXIM): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$1.03M
Year ended 2023-12-31
2014-12-31: -$339.0K2015-12-31: -$1.52M2016-12-31: -$1.29M2020-12-31: -$3.31M2021-12-31: -$2.53M2022-12-31: -$2.05M2023-12-31: -$1.03M-$1.03M
2014-12-31 Free Cash Flow (USD) 2023-12-31
Period endedFree Cash FlowChange YoYSource filing
2023-12-31-$1.03Mn/m2024-04-16, From 2023-01-01
2022-12-31-$2.05Mn/m2024-04-16, From 2022-01-01
2021-12-31-$2.53Mn/m2023-04-17, From 2021-01-01
2020-12-31-$3.31Mn/a2022-04-19, From 2020-01-01
No annual figure between 2016-12-31 and 2020-12-31.
2016-12-31-$1.29Mn/m2017-09-14, From 2016-01-01
2015-12-31-$1.52Mn/c2017-09-14, From 2015-01-01
2014-12-31-$339.0Kn/a2016-04-18, From 2014-01-01